U-M study examines age vs. menopause effects of bone health

June 19, 2003

ANN ARBOR, Mich.---Treating all middle-aged women with identical bone-protection therapies risks viewing aging and menopause as interchangeable conditions. A new study by the University of Michigan examines the difference between aging and menopause as they relate to women's bones.

"What is interesting about this study is that we took age out of the equation," principal investigator Jane Lukacs said. She is a Pfizer post-doctoral fellow and assistant research scientist at the U-M School of Nursing. Lukacs will present her findings at ENDO 2003, the Endocrine Society's annual meeting in Philadelphia June 19-22.

Studies involving hormone replacement therapy have found improvement in bone density of post-menopausal women, leading experts to infer that estrogen withdrawal at menopause is a major risk factor for osteoporosis. The question of whether the natural decline of estrogen after menopause causes bone loss has not been definitively shown.

After Lukacs and her research team found that aging-related bone loss has only a minor influence on bone function as compared to the body's natural estrogen withdrawal, which affects a number of parameters of bone health, Lukacs concluded: "Therapy should be different at different points in a woman's life."

The U-M team studied a group of women aged 20-52, and age-matched women who had and had not gone through menopause for study purposes---for example, she examined a 47-year-old woman still having regular menstrual cycles and compared her data to a 47-year-old woman who had not had regular cycles for 12 months.

She excluded women who used any form of hormones or regular prescription medication, and also eliminated smokers and heavy drinkers. Study subjects were neither, as Lukacs describes them, endurance athletes or couch potatoes.

Typically the rate of bone turnover---that is, the rate at which the body replaces old bone material with new---accelerates as women reach menopause. Because the replacement of old bone with new bone is not as efficient in menopause, a faster rate of turnover should translate to bone loss. This study examined bone biomarkers in the different groups of women to see when bone turnover increases and if measured calcium in the blood would be elevated, suggesting greater mineral loss from bones.

Most preventive bone therapies, given in the hope of protecting women against osteoporosis, slow the rate of bone turnover. But Lukacs' numbers showed pre-menopausal women did not have elevated bone turnover as they aged. "Why would you want to slow a rate of bone turnover that's normal?" Lukacs asked.

Thus, with women already nervous about hormone replacement therapy, this study gives further reason to be cautious about overprescribing hormone therapy or other conventional therapies used to slow bone turnover when it might be unnecessary in middle-aged women who still have regular menstrual cycles. Studies have shown a possible connection between HRT and cancer, as well as dementia.
The University of Michigan
News Service
412 Maynard
Ann Arbor, MI 48109-1399

A two-year, $130,000 fellowship from Pfizer helped fund Lukacs' research.

U-M School of Nursing: http://www.nursing.umich.edu/
Endocrine Society: http://www.endo-society.org/

Producers: U-M has professional TV studios and uplink capabilities.

University of Michigan

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.